A detailed history of First National Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, First National Trust CO holds 76,702 shares of ABT stock, worth $8.76 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
76,702
Previous 79,259 3.23%
Holding current value
$8.76 Million
Previous $8.24 Million 6.18%
% of portfolio
0.34%
Previous 0.34%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$100.07 - $118.13 $255,878 - $302,058
-2,557 Reduced 3.23%
76,702 $8.74 Million
Q2 2024

Aug 02, 2024

SELL
$100.73 - $112.44 $207,503 - $231,626
-2,060 Reduced 2.53%
79,259 $8.24 Million
Q1 2024

Apr 26, 2024

SELL
$109.52 - $120.96 $349,806 - $386,346
-3,194 Reduced 3.78%
81,319 $9.24 Million
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $736,311 - $901,305
-8,164 Reduced 8.81%
84,513 $9.3 Million
Q3 2023

Nov 06, 2023

SELL
$95.53 - $114.62 $265,477 - $318,528
-2,779 Reduced 2.91%
92,677 $8.98 Million
Q2 2023

Aug 01, 2023

SELL
$100.78 - $112.29 $197,831 - $220,425
-1,963 Reduced 2.02%
95,456 $10.4 Million
Q1 2023

Apr 26, 2023

BUY
$96.86 - $114.01 $10,267 - $12,085
106 Added 0.11%
97,419 $9.86 Million
Q4 2022

Feb 02, 2023

SELL
$95.06 - $111.52 $319,971 - $375,376
-3,366 Reduced 3.34%
97,313 $10.7 Million
Q3 2022

Nov 02, 2022

SELL
$96.76 - $112.03 $358,689 - $415,295
-3,707 Reduced 3.55%
100,679 $9.74 Million
Q2 2022

Aug 03, 2022

SELL
$102.07 - $123.37 $3.54 Million - $4.28 Million
-34,691 Reduced 24.94%
104,386 $11.3 Million
Q1 2022

May 03, 2022

BUY
$114.02 - $139.04 $843,177 - $1.03 Million
7,395 Added 5.62%
139,077 $16.5 Million
Q4 2021

Feb 03, 2022

BUY
$115.53 - $141.46 $381,711 - $467,383
3,304 Added 2.57%
131,682 $18.5 Million
Q3 2021

Nov 05, 2021

BUY
$116.66 - $129.06 $308,449 - $341,234
2,644 Added 2.1%
128,378 $15.2 Million
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $136,151 - $160,270
1,287 Added 1.03%
125,734 $14.6 Million
Q1 2021

May 06, 2021

BUY
$108.84 - $128.23 $426,979 - $503,046
3,923 Added 3.25%
124,447 $14.9 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $137,235 - $149,546
1,307 Added 1.1%
120,524 $13.2 Million
Q3 2020

Nov 04, 2020

BUY
$91.64 - $111.29 $433,090 - $525,956
4,726 Added 4.13%
119,217 $13 Million
Q2 2020

Aug 06, 2020

BUY
$76.57 - $98.0 $854,521 - $1.09 Million
11,160 Added 10.8%
114,491 $10.5 Million
Q1 2020

Apr 29, 2020

BUY
$62.82 - $91.86 $684,800 - $1 Million
10,901 Added 11.79%
103,331 $8.15 Million
Q4 2019

Feb 04, 2020

BUY
$78.51 - $87.4 $785 - $874
10 Added 0.01%
92,430 $8.03 Million
Q3 2019

Nov 01, 2019

BUY
$81.84 - $88.74 $27,007 - $29,284
330 Added 0.36%
92,420 $7.73 Million
Q2 2019

Jul 22, 2019

SELL
$72.88 - $85.0 $1.7 Million - $1.98 Million
-23,284 Reduced 20.18%
92,090 $7.74 Million
Q1 2019

Apr 25, 2019

SELL
$66.22 - $80.06 $619,421 - $748,881
-9,354 Reduced 7.5%
115,374 $9.22 Million
Q4 2018

Jan 28, 2019

BUY
$65.56 - $74.27 $933,771 - $1.06 Million
14,243 Added 12.89%
124,728 $9.02 Million
Q3 2018

Oct 31, 2018

BUY
$60.81 - $73.36 $298,455 - $360,050
4,908 Added 4.65%
110,485 $0
Q2 2018

Jul 30, 2018

BUY
$57.57 - $63.54 $157,856 - $174,226
2,742 Added 2.67%
105,577 $6.44 Million
Q1 2018

Apr 30, 2018

BUY
$56.27 - $63.62 $589,822 - $666,864
10,482 Added 11.35%
102,835 $6.16 Million
Q4 2017

Jan 17, 2018

BUY
$53.68 - $57.47 $735,147 - $787,051
13,695 Added 17.41%
92,353 $5.27 Million
Q3 2017

Nov 06, 2017

BUY
$48.06 - $53.64 $203,005 - $226,575
4,224 Added 5.67%
78,658 $4.2 Million
Q2 2017

Aug 07, 2017

BUY
N/A
74,434
74,434 $3.62 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track First National Trust CO Portfolio

Follow First National Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.